| Structure-activity relationships of N6-benzyladenosine-5'-uronamides as A3-selective adenosine agonists C Gallo-Rodriguez, X Ji, N Melman, BD Siegman, LH Sanders, J Orlina, ... Journal of medicinal chemistry 37 (5), 636-646, 1994 | 292 | 1994 |
| Structure-activity relationships of 8-styrylxanthines as A2-selective adenosine antagonists KA Jacobson, C Gallo-Rodriguez, N Melman, B Fischer, M Maillard, ... Journal of medicinal chemistry 36 (10), 1333-1342, 1993 | 192 | 1993 |
| Aβ40, either Soluble or Aggregated, Is a Remarkably Potent Antioxidant in Cell-Free Oxidative Systems R Baruch-Suchodolsky, B Fischer Biochemistry 48 (20), 4354-4370, 2009 | 154 | 2009 |
| Acetyl Chloride-Methanol as a Convenient Reagent for: A) Quantitative Formation of Amine Hydrochlorides B) Carboxylate Ester Formation C) Mild Removal of Nt-Boc-Protective Group. A Nudelman, Y Bechor, E Falb, B Fischer, BA Wexler, A Nudelman Synthetic communications 28 (3), 471-474, 1998 | 149 | 1998 |
| Identification of potent, selective P2Y-purinoceptor agonists: structure-activity relationships for 2-thioether derivatives of adenosine 5'-triphosphate B Fischer, JL Boyer, CHV Hoyle, AU Ziganshin, AL Brizzolara, GE Knight, ... Journal of medicinal chemistry 36 (24), 3937-3946, 1993 | 144 | 1993 |
| (15N5)-Labeled Adenine Derivatives: Synthesis and Studies of Tautomerism by 15N NMR Spectroscopy and Theoretical Calculations A Laxer, DT Major, HE Gottlieb, B Fischer The Journal of organic chemistry 66 (16), 5463-5481, 2001 | 142 | 2001 |
| Modelling the P2Y purinoceptor using rhodopsin as template AM Van Rhee, B Fischer, PJM Van Galen, KA Jacobson Drug design and discovery 13 (2), 133, 1995 | 120 | 1995 |
| Studies in sugar chemistry. 2. A simple method for O-deacylation of polyacylated sugars J Herzig, A Nudelman, HE Gottlieb, B Fischer The Journal of Organic Chemistry 51 (5), 727-730, 1986 | 120 | 1986 |
| Structure activity relationships for derivatives of adenosine‐5′‐triphosphate as agonists at P2 purinoceptors: Heterogeneity within P2x and P2y subtypes G Burnstock, B Fischer, CHV Hoyle, M Maillard, AU Ziganshin, ... Drug development research 31 (3), 206-219, 1994 | 117 | 1994 |
| 2-Thioether 5‘-O-(1-Thiotriphosphate)adenosine Derivatives as New Insulin Secretagogues Acting through P2Y-Receptors B Fischer, A Chulkin, JL Boyer, KT Harden, FP Gendron, AR Beaudoin, ... Journal of medicinal chemistry 42 (18), 3636-3646, 1999 | 89 | 1999 |
| A novel method for stereoselective glucuronidation B Fischer, A Nudelman, M Ruse, J Herzig, HE Gottlieb, E Keinan The Journal of Organic Chemistry 49 (25), 4988-4993, 1984 | 87 | 1984 |
| Protonation Studies of Modified Adenine and Adenine Nucleotides by Theoretical Calculations and 15N NMR DT Major, A Laxer, B Fischer The Journal of organic chemistry 67 (3), 790-802, 2002 | 82 | 2002 |
| Molecular Recognition of Modified Adenine Nucleotides by the P2Y1-Receptor. 1. A Synthetic, Biochemical, and NMR Approach E Halbfinger, DT Major, M Ritzmann, J Ubl, G Reiser, JL Boyer, ... Journal of medicinal chemistry 42 (26), 5325-5337, 1999 | 73 | 1999 |
| Comparative studies on the affinities of ATP derivatives for P2X‐purinoceptors in rat urinary bladder X Bo, B Fischer, M Maillard, KA Jacobson, G Burnstock British journal of pharmacology 112 (4), 1151-1159, 1994 | 72 | 1994 |
| Adenosine 5‘-O-(1-Boranotriphosphate) Derivatives as Novel P2Y1 Receptor Agonists V Nahum, G Zündorf, SA Lévesque, AR Beaudoin, G Reiser, B Fischer Journal of medicinal chemistry 45 (24), 5384-5396, 2002 | 68 | 2002 |
| Novel inhibitors of nucleoside triphosphate diphosphohydrolases: chemical synthesis and biochemical and pharmacological characterizations FP Gendron, E Halbfinger, B Fischer, M Duval, P D'Orléans-Juste, ... Journal of medicinal chemistry 43 (11), 2239-2247, 2000 | 66 | 2000 |
| An improved one-pot synthesis of nucleoside 5′-triphosphate analogues I Gillerman, B Fischer Nucleosides, Nucleotides and Nucleic Acids 29 (3), 245-256, 2010 | 60 | 2010 |
| Structure and ligand-binding site characteristics of the human P2Y11 nucleotide receptor deduced from computational modelling and mutational analysis J Zylberg, D Ecke, B Fischer, G Reiser Biochemical Journal 405 (2), 277-286, 2007 | 58 | 2007 |
| Identification of potent P2Y‐purinoceptor agonists that are derivatives of adenosine 5′‐monophosphate JL Boyer, S Siddiqi, B Fischer, T Romero‐Avila, KA Jacobson, TK Harden British journal of pharmacology 118 (8), 1959-1964, 1996 | 57 | 1996 |
| Therapeutic applications of ATP-(P2)-receptors agonists and antagonists B Fischer Expert Opinion on Therapeutic Patents 9 (4), 385-399, 1999 | 52 | 1999 |
